News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
1d
Zacks Investment Research on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...
CVS Caremark decided to return Eliquis to its formulary after negotiating a lower net cost, a spokesperson wrote in an email Tuesday. "Anticoagulant therapies are among the non-specialty products ...
CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results